openPR Logo
Press release

Global Contraceptive Drugs Market is anticipated to grow at a CAGR of 4.32% by 2027 | DelveInsight Estimates

07-20-2022 06:00 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Contraceptive Drugs Market

Contraceptive Drugs Market

Contraceptive drugs are medication with the primary action to avoid conception by preventing the fusion of the gametes by employing different techniques such as the inhibition of follicular development, ovulation which is followed majorly in oral contraceptive pills, as well as the making the environment hostile for the sperms to survive as followed by spermicidal products.

DelveInsight's Contraceptive Drugs Market Insights and Forecast report provides the current and forecasted Contraceptive Drugs Market forecasts for next five years, upcoming innovation in individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Contraceptive Drugs Market.

To know more about the Contraceptive Drugs Market Report, click here: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some facts of the Contraceptive Drugs Market are:
• Global contraceptive drugs market was valued at USD 8.59 billion in 2021, growing at a CAGR of 4.32% during the forecast period from 2022 to 2027 to reach USD 11.04 billion by 2027.
• As per the data provided by the World Health Organization (2022), 4 million women living in low and middle-income countries have unintended pregnancies annually across the globe.
• The United Nation's Department of Economic and Social Affairs 2019 statistics mentioned that approximately 922 million women of reproductive age (or their partners) use contraception methods comprising various products of which contraceptive pills are one of the most common and reliable sources for avoiding unintended pregnancies.
• Some of the key market players operating in the contraceptive drugs market includes Abbvie Inc, BAYER AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal Enterprises, Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare, Marlborough Pharmaceuticals, Teva Pharmaceuticals USA, Inc, and others

Request for free sample to know more about the Contraceptive Drugs Market facts: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key market players operating in the contraceptive drugs market includes
• Abbvie Inc
• BAYER AG
• Viatris Inc
• Gedeon Richter Plc.
• Agile Therapeutics
• Evofem Biosciences, Inc.
• Amneal Pharmaceuticals LLC.
• Pfizer Inc
• Hana
• Maxwellia Ltd.
• Piramal Enterprises
• Mankind Pharma
• HLL Lifecare Limited
• Theramex
• Besins Healthcare
• Marlborough Pharmaceuticals
• Teva Pharmaceuticals USA, Inc
• And others

To know more about the Contraceptive Companies working in the Drug Market, click here: https://www.delveinsight.com/sample-request/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developmental Activities in Contraceptive Drugs Market:
• In May 2020, the US FDA approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females with reproductive potential.
• Bayer and Daré Bioscience entered into an exclusive license agreement for the US commercial rights to investigational hormone-free, monthly contraceptive Ovaprene® in January 2020. As per this agreement, Bayer may commercialize Daré's investigational contraceptive product, Ovaprene® in the United States once approved by the FDA.
• Gedeon Richter Plc. signed an asset purchase agreement with Janssen Pharmaceutica NV on December 2020, in respect of Janssen's Outside US Evra® transdermal contraceptive patch assets. The transaction amounted to approximately around USD 263.5 million.

Know more about the recent developments in Contraceptive Drugs Market by downloading the sample page, click here: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of Contraceptive Drugs Market Report:
• Study Period: 2019-2027
• Base Year: 2021
• Forecast Period: 2022-2027
• Contraceptive Drugs Market By Product Type (Oral Contraceptive Pills [Combination And Progestin-Only], Injectables, Topical Contraceptives [Gels & Jellies, Patches, And Creams])
• Contraceptive Drugs Market By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, And Others)
• Contraceptive Drugs Market By geography ((North America, Europe, Asia-Pacific, and Rest of the World)
• Contraceptive Drugs Companies: Abbvie Inc, BAYER AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Pfizer Inc, Hana, Maxwellia Ltd., Piramal Enterprises, Mankind Pharma, HLL Lifecare Limited, Theramex, Besins Healthcare, Marlborough Pharmaceuticals, Teva Pharmaceuticals USA, Inc, and others
DelveInsight's Analysis: Global contraceptive drugs market was valued at USD 8.59 billion in 2021, growing at a CAGR of 4.32% during the forecast period from 2022 to 2027 to reach USD 11.04 billion by 2027.

Click here to know more about the Scope of the Contraceptive Drugs Market Report: https://www.delveinsight.com/report-store/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Contraceptive Drugs Market Report Introduction
2. Contraceptive Drugs & Market Executive Summary
3. Regulatory Analysis
4. Contraceptive Drugs Market Key Factors Analysis
5. Contraceptive Drugs Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Contraceptive Drugs Market
7. Contraceptive Drugs Market Layout
8. Contraceptive Drugs Market Global Company Share Analysis; Key 3-5 Companies
9. Contraceptive Drugs Market Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us

Request for Detailed TOC: https://www.delveinsight.com/sample-request/contraceptive-drugs-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Contraceptive Drugs Market is anticipated to grow at a CAGR of 4.32% by 2027 | DelveInsight Estimates here

News-ID: 2685118 • Views:

More Releases from DelveInsight Business Research

Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, According to DelveInsight
Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Advanced Renal Cell Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis b …
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast https://www.delveinsight.com/sample-request/alport-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angioedema pipeline constitutes 20+ key companies continuously working towards developing 20+ Angioedema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Angioedema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Contraceptive

Prominent Contraceptive Devices Market Trend for 2025: Innovative Products In Th …
What industry-specific factors are fueling the growth of the contraceptive devices market? The rising prevalence of sexually transmitted diseases (STDs) is expected to fuel the growth of the contraceptive device market. STDs, influenced by increased sexual activity and insufficient protection, are on the rise, making contraceptive devices, especially condoms, essential for reducing transmission risks. The UK Health Security Agency reported a 4.7% increase in new STI diagnoses in England in 2023,
Contraceptive Devices Market - Revolutionizing Family Planning: Cutting-Edge Con …
Newark, New Castle, USA: The "Contraceptive Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Contraceptive Devices Market: https://www.growthplusreports.com/report/contraceptive-devices-market/7763 This latest report researches the industry structure, sales, revenue,
Contraceptive Drugs Market: Doctors on the cusp of launching the first male cont …
Contraceptive Drugs Market by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), Age Group (15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years), and End User (Homecare, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2027. Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/9850 The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones